Sofinnova Partners is a leading European venture capital firm in life sciences, specializing
in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to laterstage. Founded in 1972, Sofinnova Partners is a deeply established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe.

Capital under management
€4+ billion in assets

Investment requirements and financing offer
Seed to late-stage investments. Flexible ticket sizes depending on strategy. Active board participation and long-term company building support.

Industry focus
Healthcare and sustainability, spanning biopharma, medtech, industrial biotech, and digital medicine.

Portfolio and exits
100+ portfolio companies across Europe and the U.S., with notable exits such as Shockwave, Amolyt, LimFlow, Mablink, CinCor.

Memberships in networks/associations
Active participant in European and global venture capital and life sciences networks, collaborating with research institutions, universities, and industry associations.

Date of foundation/ Number of employees
1972/ ~80+ professionals

Contact information

Addresses

Social Media: LinkedIn, X
Web Address: https://sofinnovapartners.com